GlassScriptPhysician profile
Brian Christopher Organ
NPI 1215015672
$9,930.15
in general payments reported to CMS, 2019-2025
17 companies · $865 in 2025
The $865 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,788 · 2020: $3,096 · 2021: $82.15 · 2022: $488 · 2023: $288 · 2024: $2,323 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,593 · Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,593.44 |
| Food and Beverage | $882.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,681.82 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $3,150.44 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medical Device Business Services, INC. | $1,810.02 | 2019 | |
| Davol INC. | $406.96 | 2019-2023 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $328.29 | 2022 | |
| Ethicon US, LLC | $239.40 | 2019 | |
| Becton, Dickinson and Company | $91.52 | 2022 | |
| Integra Lifesciences Corporation | $67.28 | 2021-2022 | |
| Merit Medical Systems INC | $29.69 | 2024 | Big60 Inflation Device |
| Innocoll Pharmaceuticals Limited | $20.52 | 2021 | |
| Acell, INC. | $18.26 | 2019 | |
| Conmed Corporation | $17.62 | 2024 | Airseal |
| Allergan, INC. | $15.86 | 2020 | |
| Solventum Corporation | $14.79 | 2025 | V.A.C. Granufoam, Prevena, Activ.A.C. |
| Medtronic, INC. | $13.22 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $13.09 | 2021 | |
| Reprise Biomedical, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Organ listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.